Animal Vaccine Industry

Summary:

• The global animal vaccine market size reached USD 13.4 Billion in 2023.
• The market is expected to reach USD 25.1 Billion by 2032, exhibiting a growth rate (CAGR) of 7.24% during 2024-2032.
• North America leads the market, accounting for the largest animal vaccine market share.
• Attenuated vaccines account for the majority of the market share in the product segment due to the growing demand for livestock products.
• Livestock animal represents the leading animal type segment, owing to the global demand for livestock products, such as meat, milk, and eggs.
• Subcutaneous accounts for the majority of the market share in the route of administration segment as this route provides a sustained release of the vaccine, leading to longer-lasting immune responses.
• The market is driven by the increasing demand for animal protein and the need to maintain animal health and productivity through vaccination programs.
• Rising incidences of zoonotic diseases and advancements in vaccine technology are contributing to the growth and adoption of animal vaccines worldwide.

Request to Get the Sample Report: https://www.imarcgroup.com/animal-vaccine-market/requestsample

Industry Trends and Drivers:

• Increasing Demand for Animal Protein:

The growing global demand for animal-based products, such as meat, milk, and eggs, is a significant driver for the animal vaccine market size. As the livestock industry continues to expand, ensuring the health and productivity of animals becomes a priority. Vaccines play a crucial role in preventing infectious diseases in animals, which can lead to high economic losses for farmers and reduce the quality of animal products. The increased focus on animal welfare and food safety has heightened the need for vaccination programs, making animal vaccines a vital component of modern livestock management. This, in turn, drives market growth as more farmers and producers recognize the importance of vaccination to safeguard their herds.

• Rising Incidences of Animal Diseases:

The rising incidences of animal diseases, particularly zoonotic diseases that can spread to humans, are significantly influencing the animal vaccine market trends. Outbreaks of diseases such as avian influenza, foot-and-mouth disease, and African swine fever have raised global awareness about the importance of vaccination in controlling these diseases. These outbreaks not only affect animal health but also pose significant risks to public health and food security. As a result, governments and regulatory bodies are increasingly promoting vaccination programs to prevent the spread of such diseases, further fueling the demand for animal vaccines across both developed and developing regions.

• Advancements in Vaccine Technology:

Continuous advancements in vaccine technology are driving the growth of the market. The development of more effective and safer vaccines, including subunit, DNA, and recombinant vaccines, has enhanced their efficacy in preventing a wide range of animal diseases. Innovations such as oral vaccines and vaccines with extended shelf lives make vaccination more accessible and convenient for farmers, especially in remote or resource-limited areas. These technological advancements also contribute to the reduced cost of vaccine production and increased adoption rates, thereby expanding the market for animal vaccines globally.

Explore Full Report with Table of Contents: https://www.imarcgroup.com/animal-vaccine-market

Animal Vaccine Market Report Segmentation:

Breakup By Product:

• Attenuated vaccines
• Inactivated vaccines
• Subunit vaccines
• Toxoid vaccines
• Conjugate vaccines
• Recombinant vaccines
• DNA vaccines Type

Attenuated vaccines account for the majority of shares due to the rising awareness about zoonotic diseases.

Breakup By Animal Type:

• Companion animal  
  • Dogs
  • Cats
• Livestock animal  
  • Cattle
  • Pigs
  • Poultry
  • Sheep
  • Others

Livestock animal accounts for the majority of shares due to the need for effective and efficient animal vaccines.

Breakup By Route of Administration:

• Subcutaneous
• Intramuscular
• Intranasal
• Others

Subcutaneous accounts for the majority of shares as it is a relatively simple and safe method.

Breakup By Region:

• North America (United States, Canada)
• Europe (Germany, France, United Kingdom, Italy, Spain, Others)
• Asia Pacific (China, Japan, India, Australia, Indonesia, Korea, Others)
• Latin America (Brazil, Mexico, Others)
• Middle East and Africa (United Arab Emirates, Saudi Arabia, Qatar, Iraq, Other)

North America holds the leading position owing to the increasing demand for livestock products.

Top Animal Vaccine Market Leaders: The animal vaccine market research report outlines a detailed analysis of the competitive landscape, offering in-depth profiles of major companies. Some of the key players in the market are:

• H. Boehringer Sohn AG & Co. KG
• Ceva Sante Animale
• Elanco Animal Health Incorporated (Eli Lilly and Company)
• Hester Biosciences Limited
• Hipra S.A.
• Hygieia Biological Laboratories
• Merck & Co. Inc.
• Phibro Animal Health Corporation
• Vaxxinova GmbH (EW Group)
• Virbae
• Zoetis Services LLC

Key highlights of the report:

• Market Performance (2018-2023)
• Market Outlook (2024-2032)
• Porter’s Five Forces Analysis
• Market Drivers and Success Factors
• SWOT Analysis
• Value Chain
• Comprehensive Mapping of the Competitive Landscape

About Us:

IMARC Group is globally recognized as a leader in market research, specializing in offering strategic management solutions and extensive market analyses across diverse industries. We collaborate with clients worldwide, focusing on identifying the most lucrative opportunities, addressing critical business challenges, and guiding significant business transformations.

Our detailed reports cover significant market, scientific, economic, and technological developments, serving business leaders in pharmaceutical, industrial, and high technology sectors. With a deep expertise in providing industry forecasts and analyses for sectors including biotechnology, advanced materials, pharmaceuticals, and food and beverage, we equip leaders with the knowledge to navigate complex markets and stay ahead of technological trends.

Contact US:

IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
Email: sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
United States: +1-631-791-1145